Mr. Wolff was most recently managing director and portfolio manager at Thiel Macro LLC. He was previously founder and managing member of Grandmaster Capital LLC, a long/short equity hedge fund from January 2011 – June 2015. Prior to founding Grandmaster Capital, from August 2005 – December 2010 Mr. Wolff was a managing director at Clarium Capital Management, the predecessor fund to Thiel Macro LLC. Mr. Wolff graduated from Harvard University in 1997 with an AB in philosophy, magna cum laude and phi beta kappa. Mr. Wolff is also a chess grandmaster and played chess professionally from 1989 – 1997, and was twice US Chess Champion, in 1992 and 1995.
Peter manages the West Coast Prime Brokerage business for Goldman Sachs and has been a relationship manager for West Coast hedge funds since moving to the San Francisco office in 2004. He is responsible for sourcing new hedge fund business and providing connectivity for current hedge fund clients to the firm’s full suite of resources. Peter joined Goldman Sachs in London in 2000 and worked in both equity and derivative sales. He was named managing director in 2011. Prior to joining the firm, Peter was a financial correspondent for Reuters news agency in London and Tokyo, covering global energy markets. Peter is a member of the Board of Directors of the charitable organization Help For Children/Hedge Funds Care. Peter earned a BA from Dartmouth College and an MBA from London Business School. He is a CFA charterholder.
Adam is co-founder and Director of Research of Aquilo Capital, a life sciences investment fund in San Francisco, California. From 2007-2010, he was a Portfolio Manager at BVF Partners, LP, where he helped manage BVF’s venture investment activities and assisted in aspects of BVF’s public markets investing. He has worked with the NIH’s Commercialization Assistance Program, UC-Davis’s Biomedical Engineering Entrepreneurship Academy, and the Michael J. Fox Foundation’s Therapeutic Development Initiative. He is a Class 14 Kauffman Fellow and co-editor of Neuroscience of Creativity, published by MIT Press. Adam did his postdoctoral training in neurobiology at Stanford University, his Ph.D. at Yale University, and his B.A. from the State University of New York at Binghamton.
Julia invests in early stage, hard science companies as as Partner at Breakout Ventures and as the Portfolio Director of Breakout Labs, a seed fund within Peter Thiel’s foundation. Earlier in her career, she was a life sciences investor with Kearney Venture Partners, a healthcare research analyst at Thomas Weisel Partners and the head of Business Development & Strategy at TriVascular. She is a graduate of the University of Virginia. Julie is also a Kauffman Fellow.